Stocks Health care CELZ
NASDAQ · Health careCreative Medical Technology Holdings, Inc. (CELZ)
Creative Medical Technology Holdings, Inc. brought in $3K of revenue over the twelve months to June 30, 2026, down 50.0% from a year earlier. It posted a net loss of $6M. At June 30, 2026 it held $8.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 7, 2026.
Key facts about Creative Medical Technology Holdings, Inc.
- Net worth
- Creative Medical Technology Holdings, Inc. has a market value (market cap) of $4.1M at the latest share price, and shareholders' equity of $8.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $6K (-45.5% year on year), with a net loss of $6M. Over the 12 months to June 30, 2026: revenue $3K, net loss $6M.
- Cash flow
- In fiscal 2025 operations used $5.9M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 7, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Creative Medical Technology Holdings, Inc.'s next report was expected around November 6, 2026 and is not on file with the SEC yet.
What Creative Medical Technology Holdings, Inc. does
Creative Medical Technology Holdings, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker CELZ.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $6K | -$6M | -$2.52 | n/a |
| 2024 | $11K | -$5.5M | -$3.71 | n/a |
| 2023 | $9K | -$5.3M | -$3.76 | n/a |
| 2022 | $88.6K | -$10.1M | -$0.93 | n/a |
| 2021 | $87.8K | $19.2M | $5.61 | n/a |
| 2020 | $164.5K | -$36.3M | -$62.69 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where CELZ ranks in Health care
Latest SEC filings
What Creative Medical Technology Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 1, 2026Activist stake (5% or more) SCHEDULE 13D
- September 25, 2026Material agreement8-KCreative Medical Technology Holdings acquired additional shares of BioDefense to increase its stake to 80 percent.
- August 31, 2026
- August 7, 2026
- July 24, 2026
- July 14, 2026Proxy statement DEF 14A
- July 2, 2026
- July 1, 2026Preliminary proxy statement PRE 14A
- June 30, 2026
- June 26, 2026
Insider trades
What the people running Creative Medical Technology Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 24, 2026 | Warbington TimothyPresident & CEO, Director, 10% owner | Received as payindirect | 1,000,000 | - |
Who owns CELZ
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Timothy Warbington13D, may seek influence with 1 related filers | 13.7% | October 1, 2026 |
Largest institutional holders
Insiders
1 insiders reported holding 1,034,904 shares in total, about $638K at the last price.
| Holder | Shares |
|---|---|
| Warbington TimothyPresident & CEO, Director, 10% owner | 1,034,9041,034,904 held indirectly |
Questions about CELZ
What does Creative Medical Technology Holdings, Inc. do?
Creative Medical Technology Holdings, Inc. is a company in the Health care sector, listed on NASDAQ as CELZ. Its shares trade on NASDAQ under the ticker CELZ.
What is Creative Medical Technology Holdings, Inc.'s net worth?
Creative Medical Technology Holdings, Inc. has a market value (market cap) of $4.1M at the latest share price, and shareholders' equity of $8.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Creative Medical Technology Holdings, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $6M on revenue of $3K.
How much revenue does Creative Medical Technology Holdings, Inc. make?
Over the twelve months to June 30, 2026 Creative Medical Technology Holdings, Inc. reported revenue of $3K. That is 50.0% less than a year earlier.
When did Creative Medical Technology Holdings, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 7, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the activist stake (5% or more) from October 1, 2026.
When is Creative Medical Technology Holdings, Inc.'s next earnings report?
Creative Medical Technology Holdings, Inc.'s next report was expected around November 6, 2026 and is not on file with the SEC yet.
Similar companies
Compare CELZ with
Follow CELZ
Get an email when Creative Medical Technology Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Creative Medical Technology Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.